What is osteoarthritis (OA)?

OA is often referred to as ‘degenerative joint disease’ and usually develops slowly, over a period of years. It is a very common disease – 6% of adults aged 30 and above have frequent knee pain. Over time, the cartilage on the surface of the joint starts to get damaged and wear away and this causes pain and stiffness in the joint.¹¹

If you suffer from arthritis you will be all too familiar with the range of symptoms that it causes and their effect upon your life.

Normal Knee

Normal cartilage provides a smooth surface so bones can move easily across each other
High concentration of hyaluronan in synovial fluid cushions and lubricates the joint
Normal bone

OA Knee

Eroded cartilage if completely worn away, bones may scrape painfully against each other
Low concentration of hyaluronan in synovial fluid less able to protect the joint
Osteophytes (bone spurs)

You may suffer from OA if you have any of these symptoms:

Stiffness in the morning
Pain when you move
Pain even when you are not active
A crackling sound or a grating feeling when walking
Red and swollen skin

Summary of Indications for Use
DUROLANE (3ml): Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been licenced for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

DUROLANE SJ (1ml): Symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

Both DUROLANE and DUROLANE SJ are also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

There are no known contraindications.

You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children.

Risks can include transient pain, swelling and/or stiffness at the injection site.

Full prescribing information can be found in product labeling (1mL / 3mL).

DUROLANE, Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC. NASHA is a registered trademark of Nestlé Skin Health S.A.

© 2019 Bioventus LLC.

^{*First introduced in the European Union in 2001.}

To learn more about DUROLANE or for contact information, please select your location to continue.

Osteoarthritis: The Ongoing Challenges to Manage Pain

Choroba zwyrodnieniowa stawów: bieżące wyzwania w zakresie radzenia sobie z bólem

[youtube_blok]https://youtu.be/m8AXUq5uA0Y[/youtube_blok]

[vimeo_blok]https://vimeo.com/281282602[/vimeo_blok]

[youtube_blok] src=https://www.youtube.com/embed/TueE6NWHtVs width=560 height=315 [/youtube_blok]

Cookie Law

Our website uses cookies, some of which are essential for this site to operate correctly and have already been set. For more information on managing, blocking or deleting cookies within your browser please refer to the references within our Privacy Policy. By using our site you accept the terms of our Privacy policy.

Settings